SINGAPORE, Aug. 12 (Xinhua) -- An investment of 3 million Singapore dollars (about 2.2 million U.S. dollars) is being pumped into tuberculosis (TB) research in Singapore, the country's Agency for Science, Technology and Research (A*STAR) said on Thursday.The project, joined by A*STAR's Singapore Immunology Network and bioindustrial group Institut Merieux, involves setting up a joint laboratory in Singapore to investigate and identify novel biomarkers that could allow early identification of individuals at risk of TB disease development and disease reactivation. Full Story
